Yabing Zheng
- Molecular Biology
- Cancer Research top 10%
- Oncology
- Pulmonary and Respiratory Medicine
- Pathology and Forensic Medicine
- Co-authors
- Yu‐An HuangXiying ShaoXiaojia WangZhanhong ChenXingfei YuHongjian YangXiangming HeXianghou Xia
- Topics
- Advanced Breast Cancer Therapies (14 papers)HER2/EGFR in Cancer Research (13 papers)Cancer Treatment and Pharmacology (8 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yabing Zheng
38 papers receiving 421 citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Molecular Biology 233
- Cancer Research 207
- Oncology 143
- Pulmonary and Respiratory Medicine 90
- Pathology and Forensic Medicine 35
Countries citing papers authored by Yabing Zheng
This map shows the geographic impact of Yabing Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yabing Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yabing Zheng more than expected).
Fields of papers citing papers by Yabing Zheng
This network shows the impact of papers produced by Yabing Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yabing Zheng. The network helps show where Yabing Zheng may publish in the future.
Co-authorship network of co-authors of Yabing Zheng
This figure shows the co-authorship network connecting the top 25 collaborators of Yabing Zheng. A scholar is included among the top collaborators of Yabing Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yabing Zheng. Yabing Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancerbreakdown → | 68 |
| 6 | 10 | |
| 7 | 3 | |
| 8 | 4 | |
| 9 | 1 | |
| 10 | 16 | |
| 11 | 6 | |
| 12 | 16 | |
| 13 | 7 | |
| 14 | 5 | |
| 15 | 25 | |
| 16 | 0 | |
| 17 | 1 | |
| 18 | 7 | |
| 19 | 11 | |
| 20 | 57 |
About Yabing Zheng
Yabing Zheng is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 425 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (14 papers), HER2/EGFR in Cancer Research (13 papers) and Cancer Treatment and Pharmacology (8 papers). The work is most often cited by research in Cancer Research (207 citations), Oncology (143 citations) and Molecular Biology (233 citations). Yabing Zheng has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yu‐An Huang, Xiying Shao, Xiaojia Wang, Zhanhong Chen, Xingfei Yu, Hongjian Yang, Xiangming He, Xianghou Xia, Wen‐Ming Cao and Huanping Zhang. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.